Brief: Opsens Announces Health Canada Approval For Its New TAVR Guidewire
26/04/2022 12:12
April 26 (Reuters) - Opsens Inc OPS.TO :
* OPSENS ANNOUNCES HEALTH CANADA APPROVAL FOR ITS NEW TAVR GUIDEWIRE
Source text for Eikon: ID:nCNWlxF13a
Further company coverage: OPS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe